Image
17.11.2022
Primary school teacher’s mental health journey with type 1 diabetes
Lili, 32, felt her experience of diagnosis aged seven was “weirdly fine”. She took control from that youn...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more